Facebook, Inc. (NASDAQ:FB): JPMorgan believes that increased clarity regarding Facebook’s regulatory filing last night is a net positive. The firm thinks that taking Mark Zuckerberg’s shares out of the upcoming lock-up expirations and minimizing the outstanding share count by 101 million via the repurchasing of shares from early employees indicates management’s confidence in Facebook’s long-term story. JPMorgan maintains an Overweight rating on the stock.
Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) announced that the U.S. government stated that it could lower the amount that Questcor is required to reimburse states for Medicaid purchases of its Acthar drug. ThinkEquity thinks that the change may have a positive impact of nearly 10 percent on the company’s 2013-2015 EPS. The firm keeps a Buy rating and a $58 target on the shares.
Starbucks Corp. (NASDAQ:SBUX): According to Oppenheimer, Starbucks may be able deliver 5 percent or higher comps going forward, and the firm believes that there are multiple positive catalysts for the company over the longer term. The firm keeps an Outperform rating and a $62 target on the stock.
Humana Inc. (NYSE:HUM): Oppenheimer predicts that Humana’s Medicare Advantage margins will make a rebound in 2013, and the firm still favors the Medicare Advantage space. It keeps an Outperform rating on the stock.
National Oilwell Varco, Inc. (NYSE:NOV): Bernstein thinks that National Oilwell will see benefits from a new wave of rig orders and an increased backlog. The firm maintains its Outperform rating on the stock.
Don’t Miss: Is This Tech Bellwether a Buy, Hold or Sell?
Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>